• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
H970182 维生素A醋酸酯干粉 retinyl acetate Other Chemical Drugs Import Drug Application 2000-01-01 罗氏(中国)投资有限公司北京办事处 Roche(China)Holding Ltd Beijing Approval Completed-Pending Certificated view
JXSS2000011 Satralizumab注射液 satralizumab Injection Biological Products Import Drug Application 2020-05-15 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-05-14 view
JXSL1700083 Gantenerumab注射液 gantenerumab Injection Biological Products Import Drug Application 2017-12-04 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2018-08-27 view
JYSB1900336 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2019-12-04 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2020-01-22 view
JYSB1500428 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2015-12-24 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2016-04-11 view
JXHL1900176 Idasanutlin片 idasanutlin Tablet Chemical Drugs(1) Import Drug Application 2019-07-31 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2019-07-30 view
JXSL1400017 Gantenerumab 注射液 gantenerumab Injection Biological Products Import Drug Application 2014-03-27 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2015-12-24 view
JYSB2000694 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2021-01-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2022-01-20 view
JXSL2000085 Gantenerumab注射液 gantenerumab Injection Biological Products Import Drug Application 2020-07-03 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-07-02 view
JYSB1900081 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2019-04-11 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2019-12-13 view
JXHB2000053 GDC-0077 inavolisib Active ingredient Chemical Drugs(1) Supplementary Application 2020-11-23 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-11-21 view
JYSB2000195 Gantenerumab注射液 gantenerumab Injection Biological Products Supplementary Application 2020-05-27 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-05-26 view
JYSB1800185 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2018-08-30 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2018-12-19 view
JXHL2000013 Idasanutlin片 idasanutlin Tablet Chemical Drugs(1) Import Drug Application 2020-02-15 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-02-14 view
JYHB1601018 马来酸咪达唑仑片 midazolam maleate Tablet Chemical Drugs Supplementary Application 2016-08-05 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2017-04-18 view
JYHZ1900224 马来酸咪达唑仑片 midazolam maleate Tablet Chemical Drugs License Renew 2019-08-17 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2019-12-20 view
JYHB1400897 甲磺酸沙奎那韦胶囊 saquinavir mesylate Capsule Chemical Drugs Supplementary Application 2014-07-04 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2016-02-15 view
JXSS2100023 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.1) Import Drug Application 2021-04-07 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2021-11-19 view
JXSL2000119 Gantenerumab注射液 gantenerumab Injection Biological Products Import Drug Application 2020-07-08 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-07-07 view
JXSL1900051 注射用 Polatuzumab vedotin polatuzumab vedotin Lyophilized Biological Products Import Drug Application 2019-05-20 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2019-05-17 view